Neostigmine and Edrophonium as Antagonists of Pancuronium in Infants and Children

The rates of recovery of neuromuscular activity following reversal of pancuronium-induced neuromuscular blockade with neostigmine or edrophonium were studied in three groups of 24 pediatric patients: “babies”—0–3 months, “infants”—3–12 months, and “children”—1–10 years.Reversal was attempted at 10%